Fig. 1From: Response criteria in solid tumors (PERCIST/RECIST) and SUVmax in early-stage non-small cell lung cancer patients treated with stereotactic body radiotherapyProgression-free survival differentiated by PERCIST/RECIST criteriaBack to article page